Prolactin and autoimmunity

Autoimmunity Reviews

Volumn 1, Issue 6, 2002, Pages 360-364

  Vera Lastra, Olga ^a   Jara, Luis J ^a   Espinoza, Luis R ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Hyperprolactinemia; Prolactin; Systemic lupus erythematosus

Indexed keywords

BROMOCRIPTINE; CYTOKINE; CYTOKINE RECEPTOR; ESTRADIOL; INTERFERON REGULATORY FACTOR 1; JANUS KINASE; PROLACTIN; PROLACTIN RECEPTOR; STAT1 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; IRF1 PROTEIN, HUMAN; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; MILK PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; TRANSACTIVATOR PROTEIN;

ADENOHYPOPHYSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME 6; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HISTOCOMPATIBILITY COMPLEX; HORMONE ACTION; HUMAN; HYPERPROLACTINEMIA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTOPOIESIS; NONHUMAN; PROLACTIN BLOOD LEVEL; PROLACTIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; GENETICS; IMMUNOGENETICS; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; AUTOIMMUNITY; DNA-BINDING PROTEINS; HUMANS; HYPERPROLACTINEMIA; IMMUNOGENETICS; INTERFERON REGULATORY FACTOR-1; JANUS KINASE 2; LUPUS ERYTHEMATOSUS, SYSTEMIC; MILK PROTEINS; PHOSPHOPROTEINS; PROLACTIN; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0041968519     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00081-2     Document Type: Review

References (32)

1. Ben-Jonathan N., Mershon J.L., Allen D.L., Steinmetz R.W. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr. Rev. 17:1996;639-669.
2. Walker S.E., Jacobson J.D. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum. Dis. Clin. North Am. 26:2000;713-736.
3. Bole-Feysot C., Goffin V., Edery M., Binart N., Kelly P.A. Prolactin (PRL) and its receptors: actions signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 19:1998;225-268.
4. Yu-Lee L. Stimulation of interferon regulatory factor-1 by prolactin. Lupus. 10:2001;691-699.
5. Hiestand P.C., Meler P., Nordmann R., Grieder A., Peramongkol C. Prolactin as a modulator of lymphocytes responsiveness provides a possible mechanism of action for prolactin. Proc. Natl. Acad. Sci. USA. 83:1986;2599-2603.
6. Montgomery D.W., Shen G.K., Ulrich E.D., Steiner L.L., Parrish P.R., Sukosky C.F. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology. 131:1992;3019-3026.
7. Matera L., Cutufia M., Geuna M., et al. Prolactin as an autocrine growth factor for the Jurkat human T-leukemic cell line. J. Neuroimmunol. 1997;7912-7921.
8. Sabharwal P., Glaser R., Lafuse W., et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc. Natl. Acad. Sci. USA. 89:1992;7713-7716.
9. Montgomery D.W. Prolactin production by immune cells. Lupus. 10:2001;665-675.
10. Hartmann D.P., Holaday J.W., Bernton E.W. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J. 3:1989;2194-2202.
11. Mukherjee P., Mastro A., Hymer W.C. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology. 126:1990;88-94.
12. Gushchin G.V., Cheney C., Glaser R., Malarkey W. Temporal relationships and IL-2 dependency of prolactin-induced lymphocyte proliferation. J. Neuroimmunol. 60:1995;93-98.
13. 2+ and protein kinase C. Int. J. Immunopharmacol. 19:1997;129-133.
14. Cesario T.C., Yousefi S., Carandang G., Sadati N., Le J., Vaziri M. Enhanced yields of γ interferon in prolactin treated human peripheral blood mononuclear cells. Proc. Soc. Exp. Biol. Med. 205:1994;898-905.
15. McMurray R.W. Bromocriptine in rheumatic and autoimmune disease. Semin. Arthritis Rheum. 31:2001;21-32.
16. Clevenger C.V., Kline J.B. Prolactin receptor signal transduction. Lupus. 10:2001;706-718.
17. Wilks A.F., Harpur A.G., Kurban R.R., Ralph S.J., Zücher G., Ziemiecki A. Two novel protein tyrosinase kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol. Cell Biol. 11:1991;2057-2065.
18. Yu-Lee L.Y., Luo G., Moutoussamy S., Finidory J. Prolactin and growth hormone signal transduction in lymphohemopoietic cells. Cell Mol. Life Sci. 54:1998;1067-1075.
19. Jara L.J., Vera-Lastra O., Miranda J.M., Alcala M., Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus. 10:2001;748-756.
20. Jacobi A.M., Rohde W., Ventz M., Riemekasten G., Burmester G.R., Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 10:2001;554-561.
21. Pacilio M., Migliaresi S., Meli R., Ambrosolo L., Bigliardo B., Di Carlo R. Elevated bioactive levels in systemic lupus erythematosus-association with disease activity. J. Rheumatol. 28:2001;2216-2221.
22. Leaños-Miranda A., Pascoe-Lira D., Chavez-Rueda K., Blanco-Favela F. Antiprolactin antibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J. Rheumatol. 28:2001;1546-1553.
23. Gutierrez M.A., Molina J.F., Jara L.J., et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) active. Lupus. 4:1995;348-352.
24. Larrea F., Martinez-Castillo A., Cabrera V., et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J. Clin. Endocrinol. Metab. 82:1997;3664-3669.
25. Cruz J., Aviña-Zubieta A., Martinez de la Escalera G., Clapp C., Lavalle C. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis Rheum. 44:2001;1331-1335.
26. Krause I., Blumenfeld Z., Malchinski M., et al. Anti-endotelial cell antibodies in the sera of hyperprolactinemic women. Lupus. 7:1998;377-382.
27. Peeva E., Grimaldi C., Spatz L., Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J. Clin. Invest. 106:2000;1373-1379.
28. Gutierrez M.A., Molina J.F., Jara L.J., et al. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int. Arch. Allergy Immunol. 109:1996;229-235.
29. Jacobi A.M., Rohde W., Volk H.-D., Dörner T., Burmenster G.-R., Hiepe F. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann. Rheum. Dis. 60:2001;242-247.
30. Hooghe R., Dogusan Z., Martens N., Velkeniers B., Hooghe P. Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus. Lupus. 10:2001;719-727.
31. Brennan P., Hajeer A., Ong K.R., et al. Allelic markers close to prolactin are associated with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 40:1997;1383-1386.
32. Stevens A., Ray D., Alansari A., et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum. 2001;2358-2366.